Frequency of Gc-globin promoter –158 (C>T) XmnI polymorphism in patients with homozygous/compound heterozygous beta thalassaemia
BACKGROUND: Response to hydroxyurea therapy in homozygous or compound heterozygous beta thalassaemia (BT) has been reported as more favourable in the presence of XmnI polymorphism. The prevalence of XmnI polymorphism may vary with BT phenotypes and genotypes, and differs geographically in distributi...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Serier: | Hematology/Oncology and Stem Cell Therapy |
| Fag: | |
| Online adgang: | https://journals.lww.com/10.1016/j.hemonc.2014.12.004 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
